![Hetaryl-[1,8]naphthyridine derivatives](/docs/US/2014-12-16/US08912216B2/abs.jpg.600x600.jpg)
- 专利标题： Hetaryl-[1,8]naphthyridine derivatives
-
申请号： US14046703申请日： 2013-10-04
-
公开(公告)号： US08912216B2公开(公告)日： 2014-12-16
- 发明人: Alfred Jonczyk , Dieter Dorsch , Guenter Hoelzemann , Christiane Amendt , Frank Zenke
- 申请人： Merck Patent GmbH
- 申请人地址： DE Darmstadt
- 专利权人： Merck Patent GmbH
- 当前专利权人： Merck Patent GmbH
- 当前专利权人地址： DE Darmstadt
- 优先权： EP10001251 20100205
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61K31/4375
![Hetaryl-[1,8]naphthyridine derivatives](/abs-image/US/2014/12/16/US08912216B2/abs.jpg.150x150.jpg)
摘要：
Novel hetaryl-[1,8]naphthyridine derivatives of formula (I) wherein R1, R2, W1, W3, W5 and W6 have the meaning according to claim 1, are inhibitors of ATP consuming proteins, and can be employed, inter alia, for the treatment of tumors.
公开/授权文献
- US20140038960A1 Hetaryl-[1,8]naphthyridine derivatives 公开/授权日：2014-02-06
信息查询
